1h
Clinical Trials Arena on MSNNeurocrine Biosciences initiates trial of VMAT2 inhibitor in healthy adultsNeurocrine Biosciences has commenced the Phase I clinical trial of its oral, small molecule vesicular monoamine transporter 2 ...
12h
Extra.ie on MSNSerial fraudster who used aliases jailed for ‘cynical’ scamA serial welfare cheat has been jailed for three years for falsely claiming over €60,000 in benefit payments by pretending ...
The Missouri Chapter of the Huntington's Disease Society of America will host a Team Hope walk Saturday, April 12, at Jackson City Park.
Corks & Forks fundraiser, benefitting the Albany chapter of the Huntington’s Disease Society of America, is coming up Friday, 3/28 from 6:00pm to 9:00pm at Duo at the ...
Multiple system atrophy (MSA) is not exactly a household word – a situation that Alterity Therapeutics is seeking to change.
ElevateBio is seeking out partnerships for its lead gene therapy after the construct reduced the levels of a toxic protein in ...
Huntington’s disease was long thought to be caused by the slow buildup of a toxic protein, but new research has reveale | ...
ClearPoint's Q4 updates: neurosurgery growth, expanding services, controlled cash burn and high-potential partner programs ...
Researchers reveal that the loss of mucin-type O-glycosylation in the brain endothelial glycocalyx weakens the blood-brain ...
Real Housewives of Dallas star Kameron Westcott is claiming that her bedridden father-in-law is succumbing to his ...
Now, using a novel system developed at Janelia, researchers led by the Dudman Lab found that a part of the basal ganglia called the striatum is not involved in action selection as previously thought.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results